Czyzewscy Kancelaria Adwokacka is recognised as a go-to advisor on issues relating to reimbursement of medicinal products; pricing of healthcare services; and advertising of drugs, food, medical devices or cosmetics. The firm is instructed by many leading international pharmaceutical companies, including Pfizer and Sanofi. Katarzyna Czyzewska heads up the practice. Maciej Huzior, who regularly advises clients on pertinent matters involving new technologies, is another name to note. In March 2022, senior associate Agnieszka Kulawiak joined the team from an in-house position at Aflofarm Group.

At Domanski Zakrzewski Palinka, the workload is split equally between project-based, strategic advice and regulatory assistance, including reacting to imminent legislative changes. Many of the team's key senior practitioners - including Michał Czarnuch and Marcin Matczak - are specialists in administrative law, operating primarily at its intersection with the pharmaceutical sector. Tomasz Kaczyński and Marcin Pieklak are noted for their expertise in product registration and reimbursement issues.

January 2022 marked a change of leadership at Dentons; although former practice head Wojciech Kozłowski continues to play an active role – particularly in the disputes space – the department is now helmed by Adam Odojewski. The team is able to handle the gamut of issues relating to pharmaceuticals and medical devices, including assisting with regulatory, distribution and advertising matters. One client singles the group out as ‘a team of experts who are making a difference‘. Maria Samolińska departed for BLSK in August 2023.

Eversheds Sutherland Poland's practice spans the whole life cycle of products and services generated by key players from the healthcare and life sciences sectors, from registration of medicinal products, to promotional and marketing strategy, to public reimbursement. The firm also assists a significant bank of clients newly entering the industry; the group's recent advice to Samsung on regulatory issues relating to its new monitoring device is just one example of this. Marta Gadomska-Gołąb and Aleksandra Kunkiel-Kryńska lead the work.

Under the guidance of its 'entrepreneurial founding partners', Małgorzata Kiełtyka and Kazimierz Jakub Gładkowski, highly specialised boutique Kieltyka Gladkowski KG Legal offers clients expertise at the intersection of technology and life sciences. The 'innovative' firm has recently advised on issues relating to biomedical engineering, distributed ledger technologies in gene therapies, patient data sharing through cloud platforms, and use of augmented reality in medical devices. The team's capabilities are further supplemented by its significant cross-border data privacy and cybersecurity experience.

Soltysinski Kawecki & Szlezak fields 'a team of top-notch lawyers' who consistently 'produce outstanding results'. The group brings together practitioners specialising in areas ranging from pharmaceutical law and biocidal products, to intellectual property and public procurement; the firm is consequently able to advise particularly well on issues occuring at the intersection of multiple fields of knowledge - including clinical trials, disputes involving healthcare entities, and projects relating to foodstuffs. Jacek Myszko and Ewa Skrzydło-Tefelska jointly lead the department.

With disputes expert Marcin Ciemiński at its helm, the offering at Clifford Chance is well placed to represent key players from the pharmaceutical, healthcare and life sciences sectors in strategic cross-border litigation, including white-collar cases relating to technology, services and products. Paweł Pogorzelski and Justyna Błazejczyk-Kuwał left the firm in early 2023.

Under the guidance of counsel Agnieszka Starzyńska, CMS Cameron McKenna Nabarro Olswang Posniak i Bejm sp.k.'s Warsaw-based team operates as part of the firm's global life sciences group, which consists of sector specialists located in over 30 countries across the world. The group is able to advise on issues arising throughout the life cycle of its clients, from the fulfilment of regulatory obligations connected with launching on the market, through to development of marketing procedures.

Kochanski & Partners‘ practice spans a wide range of issues affecting clients from the pharmaceutical and life sciences sectors, with a particular focus on marketing and advertising, medical technology, distribution, product liability, reimbursement and telemedicine. The firm’s broad outlook ensures that it is also well placed to advise on more general matters relating to employment, tax, intellectual property and corporate law. Krzysztof Zieba leads the team.

Taylor Wessing Poland's client base ranges from small innovative manufacturers of pharmaceuticals and medical devices to large hospital companies and global enterprises. The firm's key areas of expertise are manufacturing and distribution agreements; licensing and collaboration; contentious mandates, particularly in relation to patents and product liability; data protection and intellectual property; and regulatory issues. In January 2022, practice head Przemyslaw Walasek welcomed senior associate Bartosz Świdrak from Fairfield, thus strengthening the bench further.